PECAM1 and stroke disorder: We were unable to replicate these findings; this was probably due to methodological differences between the studies, most importantly that the CEC characterization was different (CD 146+CD31- in the study cited and CD146+CD31+ in our study) and also that strokes were not included as a vascular outcome in the earlier study.